Hoppa till huvudinnehållet
Uppsala universitet
  • Utbildning
  • Forskning
  • Samverkan & innovation
  • Universitetet
  • Student
  • Medarbetare
  • Alumn
  • Press
  • Bibliotek
Uppsala universitet
Uppsala universitet Uppsala universitet Institutionen för medicinsk biokemi och mikrobiologi
Institutionen för medicinsk biokemi och mikrobiologi
  • Forskningsområden
  • Forskargrupper
  • Publikationer vid IMBIM
  • Infrastruktur
  • Professor Emeriti
  • Utbildning
  • Seminarium
  • Kontakt
  • INTERN INFO
Uppsala universitet Institutionen för medicinsk ... Forskargrupper Infektion och immunitet Hughes Diarmaid Publikationer
This page in English
Lyssna
  • Forskningsområden
  • Forskargrupper
  • Publikationer vid IMBIM
  • Infrastruktur
  • Professor Emeriti
  • Utbildning
  • Seminarium
  • Kontakt
  • INTERN INFO

Publikationer

  • Discovery and Hit-to-Lead Optimization of Benzothiazole Scaffold- Based DNA Gyrase Inhibitors with Potent Activity against Acinetobacter baumannii and Pseudomonas aeruginosa.

    Cotman, A., Durcik, M., Tiz, D., Fulgheri, F., Secci, D. et al. (2023). Journal of Medicinal Chemistry, . vol. 66, ss. 1380-1425 DOI
  • Translational in vitro and in vivo PKPD modelling for apramycin against Gram-negative lung pathogens to facilitate prediction of human efficacious dose in pneumonia.

    Aranzana-Climent, V., Hughes, D., Cao, S., Tomczak, M., Urbas, M. et al. (2022). Clinical Microbiology and Infection, . vol. 28, ss. 1367-1374 DOI
  • Expert workshop summary: Advancing toward a standardized murine model to evaluate treatments for antimicrobial resistance lung infections.

    Arrazuria, R., Kerscher, B., Huber, K., Hoover, J., Lundberg, C. et al. (2022). Frontiers in Microbiology, . vol. 13 DOI
  • Variability of murine bacterial pneumonia models used to evaluate antimicrobial agents.

    Arrazuria, R., Kerscher, B., Huber, K., Hoover, J., Lundberg, C. et al. (2022). Frontiers in Microbiology, . vol. 13 DOI
  • Evolution of Bacterial Interspecies Hybrids with Enlarged Chromosomes.

    Bartke, K., Huseby, D., Brandis, G., Hughes, D. (2022). Genome Biology and Evolution, . vol. 14 DOI
  • Positive Selection during Niche Adaptation Results in Large-Scale and Irreversible Rearrangement of Chromosomal Gene Order in Bacteria.

    Cao, S., Brandis, G., Huseby, D., Hughes, D. (2022). Molecular biology and evolution, . vol. 39 DOI
  • Synthesis and in vitro biological evaluation of quinolinyl pyrimidines targeting type II NADH-dehydrogenase (NDH-2).

    Lu, L., Åkerbladh, L., Ahmad, S., Konda, V., Cao, S. et al. (2022). ACS Infectious Diseases, . vol. 8, ss. 482-498 DOI
  • Genetic Architecture and Fitness of Bacterial Interspecies Hybrids.

    Bartke, K., Garoff, L., Huseby, D., Brandis, G., Hughes, D. (2021). Molecular biology and evolution, . vol. 38, ss. 1472-1481 DOI
  • Efficacy of EBL-1003 (apramycin) against Acinetobacter baumannii lung infections in mice.

    Becker, K., Aranzana-Climent, V., Cao, S., Nilsson, A., Shariatgorji, R. et al. (2021). Clinical Microbiology and Infection, . vol. 27, ss. 1315-1321 DOI
  • Antibacterial activity of apramycin at acidic pH warrants wide therapeutic window in the treatment of complicated urinary tract infections and acute pyelonephritis.

    Becker, K., Cao, S., Nilsson, A., Erlandsson, M., Hotop, S. et al. (2021). EBioMedicine, . vol. 73 DOI
  • Antibacterial sulfonimidamide-based oligopeptides as type I signal peptidase inhibitors: Synthesis and biological evaluation.

    Benediktsdottir, A., Lu, L., Cao, S., Zamaratski, E., Karlén, A. et al. (2021). European Journal of Medicinal Chemistry, . vol. 224 DOI
  • Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy of Staphylococcus aureus infections.

    Berryhill, B., Huseby, D., McCall, I., Hughes, D., Levin, B. (2021). Proceedings of the National Academy of Sciences of the United States of America, . vol. 118 DOI
  • Expression of the qepA1 gene is induced under antibiotic exposure.

    Brandis, G., Gockel, J., Garoff, L., Guy, L., Hughes, D. (2021). Journal of Antimicrobial Chemotherapy, . vol. 76, ss. 1433-1440 DOI
  • Mutant RNA polymerase can reduce susceptibility to antibiotics via ppGpp-independent induction of a stringent-like response.

    Brandis, G., Granström, S., Leber, A., Bartke, K., Garoff, L. et al. (2021). Journal of Antimicrobial Chemotherapy, . vol. 76, ss. 606-615 DOI
  • Chromosomal Location Determines the Rate of Intrachromosomal Homologous Recombination in Salmonella.

    Garmendia, E., Brandis, G., Guy, L., Cao, S., Hughes, D. (2021). mBio, . vol. 12 DOI
  • ENABLE: an engine for European antibacterial drug discovery and development.

    Olliver, M., Griestop, L., Hughes, D., Belfrage, A., Gising, J. et al. (2021). Nature reviews. Drug discovery, vol. 20, ss. 407-408 DOI
  • Resistance/fitness trade-off is a barrier to the evolution of MarR inactivation mutants in Escherichia coli.

    Praski Alzrigat, L., Huseby, D., Brandis, G., Hughes, D. (2021). Journal of Antimicrobial Chemotherapy, . vol. 76, ss. 77-83 DOI
  • Model-Informed Drug Development for Antimicrobials: Translational PK and PK/PD Modeling to Predict an Efficacious Human Dose for Apramycin.

    Sou, T., Hansen, J., Liepinsh, E., Backlund, M., Ercan, O. et al. (2021). Clinical Pharmacology and Therapeutics, . vol. 109, ss. 1063-1073 DOI
  • Phenotypic and genetic barriers to establishment of horizontally transferred genes encoding ribosomal protection proteins.

    Yadav, K., Garoff, L., Huseby, D., Hughes, D. (2021). Journal of Antimicrobial Chemotherapy, . vol. 76, ss. 1441-1447 DOI
  • The SNAP hypothesis: Chromosomal rearrangements could emerge from positive Selection during Niche Adaptation.

    Brandis, G., Hughes, D. (2020). PLOS Genetics, . vol. 16 DOI
  • Population Bottlenecks Strongly Influence the Evolutionary Trajectory to Fluoroquinolone Resistance in Escherichia coli.

    Garoff, L., Pietsch, F., Huseby, D., Lilja, T., Brandis, G. et al. (2020). Molecular biology and evolution, . vol. 37, ss. 1637-1646 DOI
  • Antibiotic resistance by high-level intrinsic suppression of a frameshift mutation in an essential gene.

    Huseby, D., Brandis, G., Praski Alzrigat, L., Hughes, D. (2020). Proceedings of the National Academy of Sciences of the United States of America, . vol. 117, ss. 3185-3191 DOI
  • Structure-activity relationship studies on the inhibition of the bacterial translation of novel Odilorhabdins analogues.

    Loza, E., Sarciaux, M., Ikaunieks, M., Katkevics, M., Kukosha, T. et al. (2020). Bioorganic & Medicinal Chemistry, . vol. 28 DOI
  • Isopedopeptins A-H: Cationic Cyclic Lipodepsipeptides from Pedobacter cryoconitis UP508 Targeting WHO Top-Priority Carbapenem-Resistant Bacteria.

    Nord, C., Bjerketorp, J., Levenfors, J., Cao, S., Strömstedt, A. et al. (2020). ACS Chemical Biology, . vol. 15, ss. 2937-2944 DOI
  • Synthesis of New N-Acyl-1,2,3-triazole Chalcones and Determination of Their Antibacterial Activity.

    Odin, I., Cao, S., Hughes, D., Zamaratskii, E., Zarubin, Y. et al. (2020). Doklady. Chemistry, . vol. 492, ss. 89-92 DOI
  • Operon Concatenation Is an Ancient Feature That Restricts the Potential to Rearrange Bacterial Chromosomes.

    Brandis, G., Cao, S., Hughes, D. (2019). Molecular biology and evolution, vol. 36, ss. 1990-2000 DOI
  • Measuring Homologous Recombination Rates between Chromosomal Locations in Salmonella.

    Brandis, G., Cao, S., Hughes, D. (2019). Bio-protocol, . vol. 9 DOI
  • In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii.

    Juhas, M., Widlake, E., Teo, J., Huseby, D., Tyrrell, J. et al. (2019). Journal of Antimicrobial Chemotherapy, . vol. 74, ss. 944-952 DOI
  • Co-evolution with recombination affects the stability of mobile genetic element insertions within gene families of Salmonella.

    Brandis, G., Cao, S., Hughes, D. (2018). Molecular Microbiology, . vol. 108, ss. 697-710 DOI
  • Mechanisms of fitness cost reduction for rifampicin-resistant strains with deletion or duplication mutations in rpoB..

    Brandis, G., Hughes, D. (2018). Scientific Reports, vol. 8 DOI
  • Transcriptional Regulation Buffers Gene Dosage Effects on a Highly Expressed Operon in Salmonella.

    Garmendia, E., Brandis, G., Hughes, D. (2018). mBio, . vol. 9 DOI
  • Effect of aminoacyl-tRNA synthetase mutations on susceptibility to ciprofloxacin in Escherichia coli.

    Garoff, L., Huseby, D., Praski Alzrigat, L., Hughes, D. (2018). Journal of Antimicrobial Chemotherapy, vol. 73, ss. 3285-3292 DOI
  • Increased expression of Qnr is sufficient to confer clinical resistance to ciprofloxacin in Escherichia coli.

    Garoff, L., Yadav, K., Hughes, D. (2018). Journal of Antimicrobial Chemotherapy, vol. 73, ss. 348-352 DOI
  • Methods to determine mutational trajectories after experimental evolution of antibiotic resistance..

    Huseby, D., Hughes, D. (2018). Methods in Molecular Biology, New York: Humana Press. vol. 1736, ss. 95-103 DOI
  • Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones.

    Jeannot, F., Taillier, T., Despeyroux, P., Renard, S., Rey, A. et al. (2018). Journal of Medicinal Chemistry, vol. 61, ss. 3565-3581 DOI
  • Predicting mutant selection in competition experiments with ciprofloxacin-exposed Escherichia coli.

    Khan, D., Lagerbäck, P., Malmberg, C., Kristoffersson, A., Gullberg, E. et al. (2018). International Journal of Antimicrobial Agents, vol. 51, ss. 399-406 DOI
  • Odilorhabdins, Antibacterial Agents that Cause Miscoding by Binding at a New Ribosomal Site.

    Pantel, L., Florin, T., Dobosz-Bartoszek, M., Racine, E., Sarciaux, M. et al. (2018). Molecular Cell, . vol. 70, ss. 83-94 DOI
  • Boronic ester-linked macrocyclic lipopeptides as serine protease inhibitors targeting Escherichia coli type I signal peptidase.

    Szałaj, N., Lu, L., Benediktsdottir, A., Zamaratski, E., Cao, S. et al. (2018). European Journal of Medicinal Chemistry, vol. 157, ss. 1346-1360 DOI
  • Muramyl Endopeptidase Spr Contributes to Intrinsic Vancomycin Resistance in Salmonella enterica Serovar Typhimurium.

    Vestö, K., Huseby, D., Snygg, L., Wang, H., Hughes, D. et al. (2018). Frontiers in Microbiology, vol. 9 DOI
  • Selection and Transmission of Antibiotic-Resistant Bacteria.

    Andersson, D., Hughes, D. (2017). Microbiology Spectrum, vol. 5 5 DOI
  • Bacterial pathogens, antibiotics and antibiotic resistance: Editorial.

    Banin, E., Hughes, D., Kuipers, O. (2017). FEMS Microbiology Reviews, vol. 41, ss. 450-452 DOI
  • Having your cake and eating it - Staphylococcus aureus small colony variants can evolve faster growth rate without losing their antibiotic resistance.

    Brandis, G., Cao, S., Huseby, D., Hughes, D. (2017). MICROBIAL CELL, vol. 4 4, ss. 275 275-277 277 DOI
  • Alternative Evolutionary Pathways for Drug-Resistant Small Colony Variant Mutants in Staphylococcus aureus.

    Cao, S., Huseby, D., Brandis, G., Hughes, D. (2017). mBio, . vol. 8 DOI
  • Design, synthesis and in vitro biological evaluation of oligopeptides targeting E. coli type I signal peptidase (LepB).

    De Rosa, M., Lu, L., Zamaratski, E., Szałaj, N., Cao, S. et al. (2017). Bioorganic & Medicinal Chemistry, vol. 25, ss. 897-911 DOI
  • Elongation Factors: Translation.

    Hughes, D. (2017). I Reference Module in Life Sciences . DOI
  • Environmental and genetic modulation of the phenotypic expression of antibiotic resistance.

    Hughes, D., Andersson, D. (2017). FEMS Microbiology Reviews, vol. 41, ss. 374-391 DOI
  • Evolutionary Trajectories to Antibiotic Resistance.

    Hughes, D., Andersson, D. (2017). Annual Review of Microbiology, vol. 71, ss. 579-596 DOI
  • Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli.

    Huseby, D., Pietsch, F., Brandis, G., Garoff, L., Tegehall, A. et al. (2017). Molecular biology and evolution, vol. 34, ss. 1029-1039 DOI
  • Functional Constraints on Replacing an Essential Gene with Its Ancient and Modern Homologs.

    Kacar, B., Garmendia, E., Tuncbag, N., Andersson, D., Hughes, D. (2017). mBio, vol. 8 DOI
  • Can a pharmacokinetic/pharmacodynamic (PKPD) model be predictive across bacterial densities and strains?: External evaluation of a PKPD model describing longitudinal in vitro data.

    Nielsen, E., Khan, D., Cao, S., Lustig, U., Hughes, D. et al. (2017). Journal of Antimicrobial Chemotherapy, . vol. 72, ss. 3108-3116 DOI
  • The processive kinetics of gene conversion in bacteria.

    Paulsson, J., El Karoui, M., Lindell, M., Hughes, D. (2017). Molecular Microbiology, . vol. 104, ss. 752-760 DOI
  • Early-Life Human Microbiota Associated With Childhood Allergy Promotes the T Helper 17 Axis in Mice.

    Petursdottir, D., Nordlander, S., Qazi, K., Carvalho-Queiroz, C., Osman, O. et al. (2017). Frontiers in Immunology, . vol. 8 DOI
  • Ciprofloxacin selects for RNA polymerase mutations with pleiotropic antibiotic resistance effects.

    Pietsch, F., Bergman, J., Brandis, G., Marcusson, L., Zorzet, A. et al. (2017). Journal of Antimicrobial Chemotherapy, . vol. 72, ss. 75-84 DOI
  • Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli: Multiple Antibiotic-Resistance, Gram-Negative Bacteria, Multidrug Efflux Pump, Urinary-Tract-Infections, Fluoroquinolone Resistance, Quinolone Resistance, Mechanisms, Expression, Sequence, Soxs.

    Praski Alzrigat, L., Huseby, D., Brandis, G., Hughes, D. (2017). Journal of Antimicrobial Chemotherapy, vol. 2, ss. 3016-3024 DOI
  • Mechanisms and consequences of bacterial resistance to antimicrobial peptides.

    Andersson, D., Hughes, D., Kubicek-Sutherland, J. (2016). Drug resistance updates, vol. 26, ss. 43-57 DOI
  • Autoregulation of the tufB operon in Salmonella.

    Brandis, G., Bergman, J., Hughes, D. (2016). Molecular Microbiology, . vol. 100, ss. 1004-1016 DOI
  • The Selective Advantage of Synonymous Codon Usage Bias in Salmonella.

    Brandis, G., Hughes, D. (2016). PLOS Genetics, vol. 12 DOI
  • Discovery and structure-activity relationships of a novel isothiazolone class of bacterial type II topoisomerase inhibitors.

    Cooper, I., McCarroll, A., McGarry, D., Kirkham, J., Pichowicz, M. et al. (2016). Bioorganic & Medicinal Chemistry Letters, vol. 26, ss. 4179-4183 DOI
  • Using the power of genetic suppressors to probe the essential functions of RNase E.

    Hughes, D. (2016). Current Genetics, vol. 62, ss. 53-57 DOI
  • Evidence for the critical role of a secondary site rpoB mutation in the compensatory evolution and successful transmission of an MDR tuberculosis outbreak strain.

    Meftahi, N., Namouchi, A., Mhenni, B., Brandis, G., Hughes, D. et al. (2016). Journal of Antimicrobial Chemotherapy, . vol. 71, ss. 324-332 DOI
  • Comprehensive phenotypic characterization of rifampicin resistance mutations in Salmonella provides insight into the evolution of resistance in Mycobacterium tuberculosis.

    Brandis, G., Pietsch, F., Alemayehu, R., Hughes, D. (2015). Journal of Antimicrobial Chemotherapy, . vol. 70, ss. 680-685 DOI
  • Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms.

    Hughes, D., Andersson, D. (2015). Nature reviews genetics, vol. 16, ss. 459-471 DOI
  • A mechanism-based pharmacokinetic/pharmacodynamic model allows prediction of antibiotic killing from MIC values for WT and mutants.

    Khan, D., Lagerbäck, P., Cao, S., Lustig, U., Nielsen, E. et al. (2015). Journal of Antimicrobial Chemotherapy, vol. 70, ss. 3051-3060 DOI
  • Turnover of mRNAs is one of the essential functions of RNase E.

    Larsson Hammarlöf, D., Bergman, J., Garmendia, E., Hughes, D. (2015). Molecular Microbiology, vol. 98, ss. 34-45 DOI
  • Genetics: Location affects sporulation.

    Lazazzera, B., Hughes, D. (2015). Nature, vol. 525, ss. 42-43 DOI
  • Microbiological effects of sublethal levels of antibiotics.

    Andersson, D., Hughes, D. (2014). Nature Reviews Microbiology, vol. 12, ss. 465-478 DOI
  • Reducing ppGpp Level Rescues an Extreme Growth Defect Caused by Mutant EF-Tu.

    Bergman, J., Hammarlöf, D., Hughes, D. (2014). PLOS ONE, vol. 9, ss. e90486- DOI
  • Acetate availability and utilization supports the growth of mutant sub-populations on aging bacterial colonies.

    Bergman, J., Wrande, M., Hughes, D. (2014). PLOS ONE, vol. 9, ss. e109255- DOI
  • Cell-wall-inhibiting antibiotic combinations with activity against multidrug-resistant Klebsiella pneumoniae and Escherichia coli.

    Hickman, R., Hughes, D., Cars, T., Malmberg, C., Cars, O. (2014). Clinical Microbiology and Infection, vol. 20, ss. O267-O273 DOI
  • Selection and Evolution of Resistance to Antimicrobial Drugs.

    Hughes, D. (2014). IUBMB Life - A Journal of the International Union of Biochemistry and Molecular Biology, vol. 66, ss. 521-529 DOI
  • Discovery and preclinical development of new antibiotics.

    Hughes, D., Karlén, A. (2014). Upsala Journal of Medical Sciences, vol. 119, ss. 162-169 DOI
  • Mutant prevention concentrations of pradofloxacin for susceptible and mutant strains of Escherichia coli with reduced fluoroquinolone susceptibility.

    Marcusson, L., Lindgren, P., Olofsson, S., Hughes, D., Cars, O. (2014). International Journal of Antimicrobial Agents, vol. 44, ss. 354-357 DOI
  • Genetic characterization of compensatory evolution in strains carrying rpoB Ser531Leu, the rifampicin resistance mutation most frequently found in clinical isolates.

    Brandis, G., Hughes, D. (2013). Journal of Antimicrobial Chemotherapy, . vol. 68, ss. 2493-2497 DOI
  • Rifampicin Resistance: Fitness Costs and the Significance of Compensatory Evolution.

    Hughes, D., Brandis, G. (2013). Antibiotics, . vol. 2, ss. 206-216 DOI
  • Evolution of antibiotic resistance at non-lethal drug concentrations..

    Andersson, D., Hughes, D. (2012). Drug resistance updates, vol. 15, ss. 162-172 DOI
  • Fitness-compensatory mutations in rifampicin-resistant RNA polymerase.

    Brandis, G., Wrande, M., Liljas, L., Hughes, D. (2012). Molecular Microbiology, . vol. 85, ss. 142-151 DOI
  • Selection of resistance at lethal and non-lethal antibiotic concentrations.

    Hughes, D., Andersson, D. (2012). Current Opinion in Microbiology, vol. 15, ss. 555-560 DOI
  • Fitness cost: a bacteriological explanation for the demise of the first international methicillin-resistant Staphylococcus aureus epidemic.

    Nielsen, K., Pedersen, T., Udekwu, K., Petersen, A., Skov, R. et al. (2012). Journal of Antimicrobial Chemotherapy, vol. 67, ss. 1325-1332 DOI
  • Genome-Wide Detection of Spontaneous Chromosomal Rearrangements in Bacteria.

    Sun, S., Ke, R., Hughes, D., Nilsson, M., Andersson, D. (2012). PLOS ONE, vol. 7, ss. e42639- DOI
  • Persistence of antibiotic resistance in bacterial populations.

    Andersson, D., Hughes, D. (2011). FEMS Microbiology Reviews, vol. 35, ss. 901-911 DOI
  • Selection of Resistant Bacteria at Very Low Antibiotic Concentrations.

    Gullberg, E., Cao, S., Berg, O., Ilbäck, C., Sandegren, L. et al. (2011). PLoS pathogens, vol. 7, ss. e1002158- DOI
  • Temperature-sensitive mutants of RNase E in Salmonella enterica.

    Hammarlöf, D., Liljas, L., Hughes, D. (2011). Journal of Bacteriology, vol. 193, ss. 6639-6650 DOI
  • Genetic Complexity of Fusidic Acid-Resistant Small Colony Variants (SCV) in Staphylococcus aureus.

    Lannergård, J., Cao, S., Norström, T., Delgado, A., Gustafson, J. et al. (2011). PLOS ONE, vol. 6, ss. e28366- DOI
  • Can phylogenetic type predict resistance development?.

    Nazir, H., Cao, S., Hasan, F., Hughes, D. (2011). Journal of Antimicrobial Chemotherapy, vol. 66, ss. 778-787 DOI
  • Can phylogenetic type predict resistance development?.

    Nazir, H., Cao, S., Hasan, F., Hughes, D. (2011). Journal of Antimicrobial Chemotherapy, vol. 66, ss. 778-787 DOI
  • Intra- and Extracellular Activities of Dicloxacillin and Linezolid against a Clinical Staphylococcus aureus Strain with a Small-Colony-Variant Phenotype in an In Vitro Model of THP-1 Macrophages and an In Vivo Mouse Peritonitis Model.

    Sandberg, A., Lemaire, S., Van Bambeke, F., Tulkens, P., Hughes, D. et al. (2011). Antimicrobial Agents and Chemotherapy, vol. 55, ss. 1443-1452 DOI
  • Antibiotic resistance and its cost: is it possible to reverse resistance?.

    Andersson, D., Hughes, D. (2010). Nature Reviews Microbiology, vol. 8, ss. 260-271 DOI
  • The origin of mutants under selection: Interactions of mutation, growth and selection.

    Andersson, D., Hughes, D., Roth, J. (2010). I Böck et al (red.) EcoSal - Escherichia coli and Salmonella: cellular and molecular biology Washington, DC: ASM Press. DOI
  • Biological roles of translesion synthesis DNA polymerases in eubacteria.

    Andersson, D., Koskiniemi, S., Hughes, D. (2010). Molecular Microbiology, vol. 77, ss. 540-548 DOI
  • Adventures with mutation and selection in beehive and cow country.

    Hughes, D., Andersson, D. (2010). I Maloy, S., Hughes, K.T. and Casadesus, J (red.) The Lure of Bacterial Genetics, Washington, DC: ASM Press. ss. 245-253
  • Measurements of heme levels and respiration rate in Salmonella enterica serovar typhimurium.

    Hughes, D., Macvanin, M. (2010). I Gillespie, Stephen H. & McHugh, Timothy D. (red.) Antibiotic Resistance Protocols, . ss. 105-112 DOI
  • Effect of the translesion DNA polymerases, endonucleases and RpoS on mutation rates in Salmonella typhimurium.

    Koskiniemi, S., Hughes, D., Andersson, D. (2010). Genetics, vol. 185, ss. 783-795 DOI
  • Assays of sensitivity of antibiotic-resistant bacteria to hydrogen peroxide and measurement of catalase activity.

    Macvanin, M., Hughes, D. (2010). I Gillespie, Stephen H. & McHugh, Timothy D. (red.) Antibiotic Resistance Protocols, . ss. 95-103 DOI
  • Gene amplification and adaptive evolution in bacteria.

    Andersson, D., Hughes, D. (2009). Annual Review of Genetics, vol. 43, ss. 167-195 DOI
  • Genetic Determinants of Resistance to Fusidic Acid among Clinical Bacteremia Isolates of Staphylococcus aureus.

    Lannergård, J., Norström, T., Hughes, D. (2009). Antimicrobial Agents and Chemotherapy, vol. 53, ss. 2059-2065 DOI
  • Interplay in the Selection of Fluoroquinolone Resistance and Bacterial Fitness.

    Marcusson, L., Frimodt-Møller, N., Hughes, D. (2009). PLoS Pathogens, vol. 5, ss. e1000541- DOI
  • Effects of antibiotic resistance on bacterial fitness, virulence and transmission.

    Andersson, D., Hughes, D. (2008). I Baquero, Fernando Nombela, Cesar Cassell, Gail H. (red.) Evolutionary biology of bacterial and fungal pathogens, Washington DC: ASM Press. ss. 307-318
  • Mutants of the RNA-processing enzyme RNase E reverse the extreme slow-growth phenotype caused by a mutant translation factor EF-Tu.

    Hammarlöf, D., Hughes, D. (2008). Molecular Microbiology, vol. 70, ss. 1194-1209 DOI
  • Comparative genomics and the development of novel antimicrobials.

    Hughes, D. (2008). I Comparative genomics: basic and applied research, . ss. 177-192 DOI
  • Identification of the Genetic Basis for Clinical Menadione-Auxotrophic Small-Colony Variant Isolates of Staphylococcus aureus.

    Lannergård, J., von Eiff, C., Sander, G., Cordes, T., Seggewiβ, J. et al. (2008). Antimicrobial Agents and Chemotherapy, vol. 52, ss. 4017-4022 DOI
  • Accumulation of mutants in "aging" bacterial colonies is due to growth under selection, not stress-induced mutagenesis.

    Wrande, M., Roth, J., Hughes, D. (2008). Proceedings of the National Academy of Sciences of the United States of America, . vol. 105, ss. 11863-11868 DOI
  • Genetic and phenotypic identification of fusidic acid-resistant mutants with the small-colony-variant phenotype in Staphylococcus aureus.

    Norström, T., Lannergård, J., Hughes, D. (2007). Antimicrobial Agents and Chemotherapy, vol. 51, ss. 4438-4446 DOI
  • Dose-related selection of fluoroquinolone-resistant Escherichia coli.

    Olofsson, S., Marcusson, L., Strömbäck, A., Hughes, D., Cars, O. (2007). Journal of Antimicrobial Chemotherapy, vol. 60, ss. 795-801 DOI
  • Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration.

    Olofsson, S., Marcusson, L., Komp Lindgren, P., Hughes, D., Cars, O. (2006). Journal of Antimicrobial Chemotherapy, vol. 57, ss. 1116-1121 DOI
  • Weak mutators can drive the evolution of fluoroquinolone resistance in Escherichia coli.

    Örlén, H., Hughes, D. (2006). Antimicrobial Agents and Chemotherapy, vol. 50, ss. 3454-3456 DOI
  • Biological consequences for bacteria of homologous recombination.

    Hughes, D., Norström, T. (2005). I Peter Mullany (red.) The Dynamic Bacterial Genome, . ss. 351-384 DOI
  • Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections.

    Komp Lindgren, P., Marcusson, L., Sandvang, D., Fridmodt-Møller, N., Hughes, D. (2005). Antimicrobial Agents and Chemotherapy, vol. 49, ss. 2343-2351 DOI
  • Establishment of a superficial skin infection model in mice by using Staphylococcus aureus and Streptococcus pyogenes.

    Kugelberg, E., Norström, T., Petersen, T., Duvold, T., Andersson, D. et al. (2005). Antimicrobial Agents and Chemotherapy, vol. 49, ss. 3435-3441 DOI
  • Hyper-susceptibility of a fusidic acid-resistant mutant of Salmonella to different classes of antibiotics.

    Macvanin, M., Hughes, D. (2005). FEMS Microbiology Letters, vol. 247, ss. 215-220 DOI
  • Mutant prevention concentrations of ciprofloxacin for urinary tract infection isolates of Escherichia coli.

    Marcusson, L., Olofsson, S., Komp Lindgren, P., Cars, O., Hughes, D. (2005). Journal of Antimicrobial Chemotherapy, vol. 55, ss. 938-943 DOI
  • Evidence against reciprocal recombination as the basis for tuf gene conversion in Salmonella enterica serovar Typhimurium.

    Arwidsson, O., Hughes, D. (2004). Journal of Molecular Biology, vol. 338, ss. 463-467 DOI
  • Fusidic acid-resistant mutants of Salmonella enterica serovar typhimurium have low levels of heme and a reduced rate of respiration and are sensitive to oxidative stress.

    Macvanin, M., Ballagi, A., Hughes, D. (2004). Antimicrobial Agents and Chemotherapy, vol. 48, ss. 3877-3883 DOI
  • Exploiting genomics, genetics and chemistry to combat antibiotic resistance.

    Hughes, D. (2003). Nature reviews genetics, vol. 4, ss. 432-441 DOI
  • Mutation Rate and Evolution of Fluoroquinolone Resistance in Escherichia coli Isolates from Patients with Urinary tract infections.

    Komp Lindgren, P., Karlsson, Å., Hughes, D. (2003). Antimicrobial Agents and Chemotherapy, vol. 47, ss. 3222-3232 DOI
  • Fusidic acid-resistant mutants of Salmonella enterica serovar Typhimurium with low fitness in vivo are defective in RpoS induction.

    Macvanin, M., Björkman, J., Eriksson, S., Rhen, M., Andersson, D. et al. (2003). Antimicrobial Agents and Chemotherapy, vol. 47, ss. 3743-3749 DOI
  • The physiological cost of antibiotic resistance.

    Macvanin, M., Hughes, D. (2003). Recent research developments in microbiology, Trivandrum, India: Research Signpost. vol. 7, ss. 607-629
  • Target alterations mediating antibiotic resistance.

    Hughes, D., Andersson, D. (2001). I Diarmaid Hughes & Dan I Andersson (red.) Antibiotic Development and Resistance, . ss. 23-36
  • Antibiotic Development and Resistance.

    Hughes, Diarmaid; Andersson, Dan I, 2001
  • Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus.

    Nagaev, I., Björkman, J., Andersson, D., Hughes, D. (2001). Molecular Microbiology, . vol. 40, ss. 433-439 DOI
  • Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance.

    Björkman, J., Nagaev, I., Berg, O., Hughes, D., Andersson, D. (2000). Science, . vol. 287, ss. 1479-1482 DOI
  • Co-evolution of the tuf genes links gene conversion with the generation of chromosomal inversions.

    Hughes, D. (2000). Journal of Molecular Biology, . vol. 297, ss. 355-364 DOI
  • Evaluating genome dynamics: the constraints on rearrangements within bacterial genomes.

    Hughes, D. (2000). Genome Biology, vol. 1, ss. 0006.1-0006.8 DOI
  • Structure of a mutant EF-G reveals domain III and possibly the fusidic acid binding site.

    Laurberg, M., Kristensen, O., Martemyanov, K., Gudkov, A., Nagaev, I. et al. (2000). Journal of Molecular Biology, vol. 303, ss. 593-603 DOI
  • Fusidic acid-resistant EF-G perturbs the accumulation of ppGpp.

    Macvanin, M., Johanson, U., Ehrenberg, M., Hughes, D. (2000). Molecular Microbiology, . vol. 37, ss. 98-107 DOI
  • Novel ribosomal mutations affecting translational accuracy, antibiotic resistance and virulence of Salmonella typhimurium.

    Björkman, J., Samuelsson, P., Andersson, D., Hughes, D. (1999). Molecular Microbiology, . vol. 31, ss. 53-58 DOI
  • Impact of homologous recombination and gene conversion on genomic organisation and stability.

    Hughes, D. (1999). I Robert L. Charlebois (red.) Organization of the prokaryotic genome, . ss. 109-128
  • Antibiotikaresistens här för att stanna?.

    Andersson, D., Björkman, J., Hughes, D. (1998). Läkartidningen, vol. 95, ss. 3940-3944
  • Virulence of antibiotic-resistant Salmonella typhimurium.

    Bjorkman, J., Hughes, D., Andersson, D. (1998). PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, . vol. 95, ss. 3949-3953
  • Carbon starvation of Salmonella typhimurium does not cause a general increase of mutation rates.

    Hughes, D., Andersson, D. (1997). JOURNAL OF BACTERIOLOGY, . vol. 179, ss. 6688-6691
  • Mutants of EF-Tu defective in binding aminoacyl-tRNA.

    Abdulkarim, F., Ehrenberg, M., Hughes, D. (1996). FEBS Letters, vol. 382, ss. 297-303 DOI
  • Homologous recombination between the tuf genes of Salmonella typhimurium.

    Abdulkarim, F., Hughes, D. (1996). Journal of Molecular Biology, vol. 260, ss. 506-522 DOI
  • Muller's ratchet decreases fitness of a DNA-based microbe.

    Andersson, D., Hughes, D. (1996). Proceedings of the National Academy of Sciences of the United States of America, vol. 93, ss. 906-907
  • The dynamic structure of EF-G studied by fusidic acid resistance and internal revertants.

    Johanson, U., AEvarsson, A., Liljas, A., Hughes, D. (1996). JOURNAL OF MOLECULAR BIOLOGY, . vol. 258, ss. 420-432
  • Limitations of translational accuracy.

    Kurland, C., Hughes, D., Ehrenberg, M. (1996). I Escherichia coli and Salmonella, . ss. 979-1004
  • tRNA-ribosome interactions.

    Ehrenberg, M., Bilgin, N., Dincbas, V., Karimi, R., Hughes, D. et al. (1995). Biochemistry and Cell Biology, vol. 73, ss. 1049-1054
  • A new mutation in 16S rRNA of Escherichia coli conferring spectinomycin resistance.

    Johanson, U., Hughes, D. (1995). Nucleic Acids Research, vol. 23, ss. 464-466
  • Mutations to kirromycin resistance occur in the interface of domains I and III of EF-Tu.GTP.

    Abdulkarim, F., Liljas, L., Hughes, D. (1994). FEBS Letters, vol. 352, ss. 118-122 DOI
  • Fusidic acid-resistant mutants define three regions in elongation factor G of Salmonella typhimurium.

    Johanson, U., Hughes, D. (1994). Gene, vol. 143, ss. 55-59 DOI
  • Ternary complex-ribosome interaction: its influence on protein synthesis and on growth rate.

    Hughes, D., Tubulekas, I. (1993). Biochemical Society Transactions, vol. 21, ss. 851-857
  • A single amino acid substitution in elongation factor Tu disrupts interaction between the ternary complex and the ribosome.

    Tubulekas, I., Hughes, D. (1993). Journal of Bacteriology, vol. 175, ss. 240-250
  • Growth and translation elongation rate are sensitive to the concentration of EF-Tu.

    Tubulekas, I., Hughes, D. (1993). Molecular Microbiology, vol. 8, ss. 761-770 DOI
  • Suppression of rpsL phenotypes by tuf mutations reveals a unique relationship between translation elongation and growth rate.

    Tubulekas, I., Hughes, D. (1993). Molecular Microbiology, vol. 7, ss. 275-284 DOI
  • Comparison of the complete sequence of the str operon in Salmonella typhimurium and Escherichia coli.

    Johanson, U., Hughes, D. (1992). Gene, vol. 120, ss. 93-98 DOI
  • Missense substitutions lethal to essential functions of EF-Tu.

    Abdulkarim, F., Tuohy, T., Buckingham, R., Hughes, D. (1991). Biochimie, vol. 73, ss. 1457-1464 DOI
  • Error-prone EF-Tu reduces in vivo enzyme activity and cellular growth rate.

    Hughes, D. (1991). Molecular Microbiology, vol. 5, ss. 623-630
  • The nucleotide sequence of rpsL and its flanking regions in Salmonella typhimurium.

    Hughes, D., Buckingham, R. (1991). Gene, vol. 104, ss. 123-124 DOI
  • Mutant ribosomes can generate dominant kirromycin resistance.

    Tubulekas, I., Buckingham, R., Hughes, D. (1991). Journal of Bacteriology, vol. 173, ss. 3635-3643
  • Both genes for EF-Tu in Salmonella typhimurium are individually dispensible for growth.

    Hughes, D. (1990). Journal of Molecular Biology, vol. 215, ss. 41-51 DOI
  • Overproduction of release factor reduces spontaneous frameshifting and frameshift suppression by mutant elongation factor Tu.

    Rydén Aulin, M., Hughes, D. (1990). Journal of Bacteriology, vol. 172, ss. 6721-6726
  • The role of EF-Tu and other translation components in determining translocation step size.

    Tuohy, T., Thompson, S., Gesteland, R., Hughes, D., Atkins, J. (1990). Biochimica et Biophysica Acta, Gene Structure and Expression, vol. 1050, ss. 274-278 DOI
  • Resistance to fusidic acid can be linked to the Small Colony Variant (SCV) phenotype in Staphylococcus aureus.

    Norström, T., Hughes, D.
Skriv ut

Vill du kontakta oss?

Postadress
IMBIM 
Box 582, 751 23 Uppsala

Telefon: 018 - 471 44 44
E-post: imbim@imbim.uu.se

Ska du besöka oss?

Besöksadress
BMC, Husargatan 3 
C8:3, ing. C7
Uppsala

Hitta hit

Genvägar

Apparatlista/inventarielista
Gör ditt projektarbete hos oss
IMBIM dokument
IMBIM dokument för undervisning
IMBIM Handbook
Personal vid IMBIM 2022
Post doc hos IMBIM
 

© Uppsala universitet Telefon: 018-471 00 00 Box 256, 751 05 Uppsala

Organisationsnummer: 202100-2932 Momsregistreringsnummer: SE202100293201 PIC: 999985029 Registrator Om webbplatsen Dataskyddspolicy Sidansvarig: Veronica Hammar

Uppsala universitet använder kakor (cookies) för att webbplatsen ska fungera bra för dig. Läs mer om kakor.